Form 4: Dexcom Executive Sells Shares
Insider Transaction (Form 4)
Kevin R Sayer, Executive Chair and a Director of Dexcom Inc, sold 26,756 shares of common stock on August 20, 2026.
Summary
- Open-market sale: disposed of 19,308 Common Stock at $89.71 ($1,732,043) on August 20, 2026; holds 309,662 after (Direct).
- Open-market sale: disposed of 7,351 Common Stock at $90.78 ($667,332) on August 20, 2026; holds 302,311 after (Direct).
- Open-market sale: disposed of 97 Common Stock at $91.41 ($8,867) on August 20, 2026; holds 302,214 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,408,242 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Kevin R Sayer — Director, Officer (Executive Chair)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-20 | Open-market sale | Common Stock | 19,308 | $90 | $1.7M | 309,662 |
| 2026-08-20 | Open-market sale | Common Stock | 7,351 | $91 | $667.3K | 302,311 |
| 2026-08-20 | Open-market sale | Common Stock | 97 | $91 | $8.9K | 302,214 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-20 | Open-market sale (19,308 shares) |
| 2026-08-20 | Open-market sale (7,351 shares) |
| 2026-08-20 | Open-market sale (97 shares) |
Keywords
insider transaction, Form 4, DXCM, DEXCOM INC, bearish, Kevin R Sayer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.